Azetidinones as vasopressin V1a antagonists
- 23 December 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (5) , 2054-2080
- https://doi.org/10.1016/j.bmc.2006.12.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptorBioorganic & Medicinal Chemistry, 2005
- Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptorsPharmacological Research, 2005
- Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- Functional and Pharmacological Characterization of the First Specific Agonist and Antagonist for the V1b Receptor in MammalsStress, 2003
- A novel G protein-coupled receptor mediating both vasopressin- and oxytocin-like functions of Lys-conopressin in Lymnaea stagnalisNeuron, 1995
- Molecular cloning of the receptor for human antidiuretic hormoneNature, 1992
- Structure and expression of a human oxytocin receptorNature, 1992
- Molecular cloning and expression of a rat Via arginine vasopressin receptorNature, 1992
- LH-RH antagonists: design and synthesis of a novel series of peptidomimeticsJournal of Medicinal Chemistry, 1989
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988